Data Mining for High Dimensional Data in Drug Discovery and Development.
- Author:
Kwan R LEE
1
;
Daniel C PARK
;
Xiwu LIN
;
Sergio ESLAVA
Author Information
1. GlaxoSmithKline, Research & Development, Data Exploration Sciences 1250 South Collegeville Road Collegeville, PA 19426, USA. kwan.lee@gsk.com
- Publication Type:Clinical Trial ; Original Article
- Keywords:
data mining;
high dimensional data, genomics;
proteomics, pharmacogenomics
- MeSH:
Classification;
Data Mining*;
Dataset;
Decision Trees;
Disease Management;
Drug Discovery*;
Genomics;
Proteomics;
Retrospective Studies;
Statistics as Topic
- From:Genomics & Informatics
2003;1(2):65-74
- CountryRepublic of Korea
- Language:English
-
Abstract:
Data mining differs primarily from traditional data analysis on an important dimension, namely the scale of the data. That is the reason why not only statistical but also computer science principles are needed to extract information from large data sets. In this paper we briefly review data mining, its characteristics, typical data mining algorithms, and potential and ongoing applications of data mining at biopharmaceutical industries. The distinguishing characteristics of data mining lie in its understandability, scalability, its problem driven nature, and its analysis of retrospective or observational data in contrast to experimentally designed data. At a high level one can identify three types of problems for which data mining is useful: description, prediction and search. Brief review of data mining algorithms include decision trees and rules, nonlinear classification methods, memory-based methods, model-based clustering, and graphical dependency models. Application areas covered are discovery compound libraries, clinical trial and disease management data, genomics and proteomics, structural databases for candidate drug compounds, and other applications of pharmaceutical relevance.
